Research Spotlight – December 2018

Our December edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

This month’s selected research publications cover disease areas from arthritis to diabetes to Parkinson’s and include studies that examine NK cells and PD-L1 expressions.

Scroll down to learn more about these new scientific discoveries.

SIRT1 activation promotes angiogenesis in diabetic wounds by protecting endothelial cells against oxidative stress

Authors: Li, X., Wu, G., Han, F., Wang, K., Bai, X., Jia, Y., Li, Z., Cai, W...
Journal: Archives of Biochemistry and Biophysics

Objective: Chronic wounds are a devastating complication of diabetes and can lead to amputations or even death. Current medical therapies are insufficient to accelerate its repair. The objective of this study was to explore the role of Sirtuin1 (SIRT1) in…

Read More

Cited Boster Product(s): Goat Anti-Rabbit IgG (H+L) Secondary Antibody, HRP Conjugate (BA1054); IgG (H+L) Secondary Antibody, HRP Conjugate (BA1050)

Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome

Authors: Peng, X., Yang, T., Liu, G. Liu, H., Peng, Y., & He, L.
Journal: International Immunopharmacology

Background: Lupus nephritis (LN) is a leading cause of mortality. The activation of NLRP3 inflammasome contributed to LN development and thus became a therapeutic target. Here we assessed the therapeutic potential of piperine, a bioactive…

Read More

Cited Boster Product(s): Mouse IL-1 Beta PicoKine™ ELISA Kit (EK0394); Human IL-1 Beta PicoKine™ ELISA Kit (EK0392); Human IL-18 PicoKine™ ELISA Kit (EK0864)

Effect of miR-30e regulating NK cell activities on immune tolerance of maternal-fetal interface by targeting PRF1

Authors: Huang, Q., Ding, J., Gong, M., Wei, M., Zhao, Q., & Yang, J.
Journal: Biomedicine & Pharmacotherapy

Aim: Natural killer (NK) cells, as key regulatory cells, accumulate at the maternal-fetal interface in large numbers. This study explored the effect of miR-30e on regulating the activity and function of peripheral blood NK cells (PB-NK cells) and decidua NK cells…

Read More

Cited Boster Product(s): BCA Protein Assay Kit (AR0146); SDS-PAGE Gel Preparation Kit (AR0138)

Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection

Authors: Zhou, J., Liu, Z., Chen, M., Luo, Z.H., Li, Y.Q., Qi, G.Y., & Liu, T.
Journal: Diabetes Therapy

Introduction: Conbercept is a new anti-vascular endothelial growth factor drug approved for the treatment of age-related macular degeneration by the China Food and Drug Administration (CFDA) in 2013. In this study, we for the first time evaluated the...

Read More

Cited Boster Product(s): Human VEGF PicoKine™ ELISA Kit (EK0539); Human PLGF PicoKine™ ELISA Kit (EK0490)

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

Authors: Marques, T.M., van Rumund, A., Bruinsma, I.B., Wessels, H.J.C.T...
Journal: Molecular Neurobiology

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in elderly people. Currently, the diagnosis of PD is based on neurological examination, neuroimaging, and the response to dopaminergic medication. The diagnosis...

Read More

Cited Boster Product(s): Human Galectin-1 PicoKine™ ELISA Kit (EK0762)

Cinnamaldehyde ameliorates STZ-induced rat diabetes through modulation of IRS1/PI3K/AKT2 pathway and AGEs/RAGE interaction

Authors: Abdelmageed, M.E., Shehatou, G.S., Abdelsalam, R.A., Suddek...
Journal: Naunyn-Schmiedeberg's Archives of Pharmacology

Type 2 diabetes mellitus (T2D) is a chronic metabolic disorder considered to be the most predominant form of diabetes throughout the world. This study aimed to investigate the possible effects of cinnamaldehyde (CIN) on insulin signaling pathways in STZ-induced…

Read More

Cited Boster Product(s): Rat RAGE PicoKine™ ELISA Kit (EK0971)

Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy

Authors: Guan, X., Lin, L., Chen, J., Hu, Y., Sun, P., Tian, H., Maruyama, A...
Journal: Journal of Controlled Release

The immune checkpoint blockade of programmed death ligand-1 (PD-L1) or programmed death-1 (PD-1) has been a promising strategy to restore T cell mediated tumor suppression. In this study, a plasmid DNA which expressed small hairpin RNA...

Read More

Cited Boster Product(s): FITC Conjugated Avidin (BA1125); Cy3 Conjugated Avidin (BA1037)

Autocrine VEGF signalling on M2 macrophages regulates PD‐L1 expression for immunomodulation of T cells

Authors: Lai, Y.S., Wahyuningtyas, R., Aui, S.P., & Chang, K.T.
Journal: Journal of Cellular and Molecular Medicine

M2‐polarized macrophages, on one hand, can promote tumour vascularization by producing proangiogenic factors, such as vascular endothelial growth factor (VEGF). On the other hand, the expression of VEGF receptors (VEGFR) in this cell lineage was also…

Read More

Cited Boster Product(s): Mouse VEGF PicoKine™ ELISA Kit (EK0541)

The involvement of C5a in the progression of experimental arthritis with Porphyromonas gingivalis infection in SKG mice

Authors: Munenaga, S., Ouhara, K., Hamamoto, Y., Kajiya, M., Takeda, K...
Journal: Arthritis Research & Therapy

Background: Epidemiological evidence to suggest that periodontal disease (PD) is involved in the progression of rheumatoid arthritis (RA) is increasing. The complement system plays a critical role in immune responses. C5a has been implicated in...

Read More

Cited Boster Product(s): Mouse Complement C5a PicoKine™ ELISA Kit (EK0987)

GDF11 antagonizes TNF-α–induced inflammation and protects against the development of inflammatory arthritis in mice

Authors: Li, W., Wang, W., Liu, L., Qu, R., Chen, X., Qiu, C., Li, J., Hayball, J...
Journal: The FASEB Journal

Growth differentiation factor 11 (GDF11), a key member of the TGF-β superfamily, plays critical roles in various medical conditions. Recently, GDF11 was found to suppress the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway...

Read More

Cited Boster Product(s): IHC Enzyme Antigen Retrieval Reagent (AR0022)